Autopsy report · NCT04834310

Postoperative Antibiotics Following Primary and Secondary Breast Augmentation

“Do not have adequate funding to proceed with project.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of California, Los Angeles

Sponsor type

University, hospital or other

Conditions

Surgical Site Infection; Capsular Contracture Associated With Breast Implant; Antibiotic Resistant Infection; Antibiotic Side Effect

Interventions

Cefazolin; Cephalexin; Placebo

Participants

0

Trials that died the same way

• A Community-based Resilience Program of Only-child Loss Parents
  “Don't have enough funding to finish the project.” (86% match in meaning)
• Essential Amino Acids and Parkinsons Disease
  “project not funded” (80% match in meaning)
• Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers
  “Insufficient funding” (76% match in meaning)
• Brain-imaging and Adolescent Neuroscience Consortium
  “The project was not funded.” (74% match in meaning)
• Creatine Supplementation for Improved Voice Performance in the Elderly
  “Project is on indefinite hold due to a lack of funding” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.